Hodgkin lymphoma trials in France

In France 21 Also abroad 155

21 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
Where
Le Mans Cedex 9, Lille, Limoges, Montpellier Cedex 5, Paris, Pessac, Pierre-Bénite
Age
18 years and over
People
118 worldwide
Run by
Ryvu Therapeutics S.A.
See details and how to join2024-513098-31-00 · EU 2024-513098-31-00
Phase 2Taking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
Grenoble Cedex 9, Montpellier Cedex 5, Pessac, Rennes Cedex 9, Tours Cedex 9
Age
18 years and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
Phase 1/2Taking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Clermont-Ferrand, Dijon, Montpellier Cedex 5, Nice, Paris
Age
18 years and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
Phase 1/2Taking people
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Where
Bordeaux, Villejuif
Age
Up to 17 years
People
37 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00
Phase 1Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Where
Lille, Marseille, Nantes, Paris, Toulouse, Villejuif
Age
18 years and over
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00
Phase 1Taking people
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Where
Nantes, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00
Phase 1Taking people
A Study of ARC-02 in B-cell NHL
Where
Creteil Cedex, Lille, Nantes, Pierre-Bénite, Villejuif Cedex
Age
18 years and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
Phase 1/2Taking people
A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
Where
Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
Age
18 years and over
People
48 worldwide
Run by
Cellectis
See details and how to joinNCT05607420 · EU 2022-501607-27-00
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Montpellier Cedex 5, Paris Cedex 10, Pierre-Bénite, Rouen Cedex
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
Phase 1/2Taking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
Age
12 years and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
Phase 3Taking people
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Where
Brest, Nantes Cedex 2, Tours
Age
18 years and over
People
49 worldwide
Run by
Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00
Phase 1/2Taking people
A study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
Where
Pierre-Bénite, Rennes, Villejuif
Age
18 years and over
People
30 worldwide
Run by
Glaxosmithkline Research & Development Limited
See details and how to join2025-524915-36-00 · EU 2025-524915-36-00
Phase 2Taking people
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Where
Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Nancy, Nantes, Nice, Paris, Pessac, Poitiers, Rouen, Saint-Etienne, Toulouse
Age
18 years and over
People
150
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT04935684
Phase 1Taking people
A Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas
Where
Paris, Pessac, Villejuif
Age
18 years and over
People
42 worldwide
Run by
Regeneron Pharmaceuticals Inc.
See details and how to joinNCT05685173 · EU 2022-502137-26-00
Phase 1/2Taking people
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Where
Paris, Villejuif
Age
6 months to 17 years
People
370 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00
No phaseTaking people
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Where
Montpellier
Age
18 years and over
People
500
Run by
University Hospital, Montpellier
See details and how to joinNCT02134574
Phase 4Taking people
ETCABio - Evaluation of Skin Tests in Biotherapy Allergies
Where
Angers
Age
18 years and over
People
140
Run by
Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 · EU 2024-519812-15-00
Phase 2/3Taking people
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Where
Bordeaux Cedex, Lyon Cedex 08, Villejuif
Age
Up to 25 years
People
210 worldwide
Run by
University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00
Phase 1Taking people
Study of SGR-1505 in Mature B-Cell Neoplasms
Where
Creteil Cedex, Villejuif
Age
18 years and over
People
98 worldwide
Run by
Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00
No phaseNot yet taking people in France
Hodgkin's Disease and Chemotherapy Before 40 Years
Where
Arras, Lille, Lomme, Roubaix
Age
18 years to 40 years
People
63
Run by
Lille Catholic University
See details and how to joinNCT06116929
No phaseTaking people
REal World Data in LYmphoma and Survival in Adults
Where
Arras, Besançon, Bordeaux, Bourgoin, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Dunkirk, Grenoble, La Roche-sur-Yon, La Tronche, Le Mans, Libourne, Lille, Limoges, Lyon, Montpellier, Mulhouse, Nantes, Niort, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Roubaix, Rouen, Saint-Brieuc, Saint-Cloud, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Vannes
Age
18 years and over
People
6,000
Run by
Hospices Civils de Lyon
See details and how to joinNCT03869619